Stratedigm unveils its next revolutionary product: The Visual Protocol Designer (VPD). Cytometry’s most advanced automation platform is now even better. With VPD’s patent-pending GUI-based autonomous engine, users craft complex protocols effortlessly with simple drag-and-drop operations.
VPD gives even more power to your A600 HTAS, while maintaining simplicity. And it all comes together with Stratedigm’s fully integrated Acquisition and Analysis software, CellCapTure. Scientists and researchers can utilize well-to-well pipetting, enhanced mixing, recording, and incubating without any programming knowledge. Additionally, the GUI-based autonomous engine perceptively decides the next step in your assay based on user data. These advanced features enable VPD to accelerate research in drug discovery, pathogen screening, cancer therapeutics, and precision medicine by a hundred-fold, ushering in a new era of Predictive Cytometry.
True to Stratedigm’s ongoing commitment to investment protection, VPD’s patent-pending technology is fully compatible with Stratedigm’s legacy instruments. “Our strategy to develop future-proof products ensures access to our latest innovations without the disruptions of any hardware and software obsolescence,” said Shervin Javadi, Stratedigm CEO.
To learn more about Stratedigm’s VPD, please contact firstname.lastname@example.org or visit our website at https://www.stratedigm.com/visual-protocol-designer.